Journal of neural transmission. Parkinson's disease and dementia section
about
Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP)The effects of alpha-2 adrenoceptor antagonist, atipamezole, on spatial learning in scopolamine-treated and aged ratsBehavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's diseaseNeuromelanin synthesis in rat and human substantia nigra.Glutamate receptor antagonists for neuroleptic malignant syndrome and akinetic hyperthermic parkinsonian crisis.MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.Release signs in Parkinson's disease with and without dementia.The interaction of L-deprenyl and scopolamine on spatial learning/memory in rats.Brain and cerebrospinal fluid cholinesterases in Alzheimer's disease, Parkinson's disease and aging. A critical review of clinical and experimental studies.Effects of botulinum neurotoxin and Lambert-Eaton myasthenic syndrome IgG at mouse nerve terminals.Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans.Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease.Juvenile Parkinson's disease and its response to L-dopa therapy.The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis.The role of excitatory amino acids in experimental models of Parkinson's disease.Genetic factors in the etiology of idiopathic Parkinson's disease.Sporadic dementia of Alzheimer type: role of amyloid in etiology is challenged.The neural mechanisms and progressive nature of symptoms of Parkinson's disease--based on clinical, neurophysiological and morphological studies.Topographic mapping of long latency "cognitive" event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia.Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease.Levels of pros-methylimidazoleacetic acid: correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated mice.The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra.Influence of gonadal hormones on sexual differences in sensitivity to methamphetamine-induced neurotoxicity.Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid.Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine.Glutamate-dopamine interactions in the production of pilocarpine motor seizures in the mouse.Disordered dopamine neurotransmission in the striatum of rats undergoing pilocarpine-induced generalized seizures, as revealed by microdialysis.A quantitative study of levodopa-induced dyskinesia in Parkinson's disease.Attenuation of haloperidol-induced catalepsy by noradrenaline and L-threo-DOPS.3H-spiperone binding to lymphocytes fails in the differential diagnosis of de novo Parkinson syndromes.Effect of repeated electroconvulsive shock on striatal L-dopa and dopamine metabolism: an in vivo study.Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features.Does reserpine induce parkinsonian rigidity?Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor.Long-term observation of chronic subcutaneous administration of lisuride in the treatment of motor fluctuations in Parkinson's disease.The effects of alaproclate and p-chlorophenylalanine on cued navigation performance in rats.Changes in pyruvate dehydrogenase complex (PDHc) activity and [3H]QNB-receptor binding in rat brain subsequent to intracerebroventricular injection of bromopyruvate.Quantification of motor deficit in Parkinson's disease with a motor performance test series.Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases.Investigation of the mechanism of the effect of tacrine (tetrahydroaminoacridine) on the metabolism of acetylcholine and choline in brain cortical prisms.
P1433
Q28279215-D9747AAA-E4A1-46F4-85A1-F805B562C27FQ28327426-D42C1690-FE4D-4FF0-B956-419B85ADAF02Q28334363-35D52AD4-E444-411A-961E-4B75B1202878Q34036286-00B49709-63A0-48EC-BBA4-3E70F534CB0DQ34335511-57800478-C152-441E-A1D9-4B4AB259A482Q34476329-E97692A3-7789-403D-915F-07B661FB1CCFQ34562372-9229577E-2345-4B98-89EB-A29628F963ADQ34727306-343AE89A-1922-491F-A443-45D5C00D5383Q35352940-F4A80D97-D936-429B-9A32-F2C2A00F3380Q35513341-D5A9F050-6188-4A4D-BEEF-1D483FD499BDQ36533717-9ABA61D9-E667-418F-903A-78175632EA9FQ36921692-30DB9884-C872-4FD4-B375-4513B96946B2Q38097762-3696A15F-E1DA-43B8-8A56-417F3AD8E84DQ39378597-A047ACC2-8FB2-4CE0-81D8-D73EDC8B8237Q40398681-5C8D19F3-A701-4817-B594-F9069B865F37Q40614172-6BAC2F77-BF2D-4BBF-8928-F6567C524982Q40722292-9DAFEBE6-5AF9-4C9A-AB79-94B79A8E4643Q40981352-1BD42E10-860C-4C2F-BA0A-9AA384BDCE08Q41095055-72CB899D-A03E-4519-86A8-ACB710E66A63Q41132727-7EAEEAE6-BC91-487F-9EDA-B7E397A6ACE5Q41164734-7D458B30-5334-4425-AF48-1B219EA7227CQ42192455-B249FE64-B5FA-4DD5-9ABC-C0EBEE2E9BC4Q42275689-F1712E92-EAD8-4AFA-9649-5D639D431EEDQ42278005-D0D9B22B-6E6C-4E75-A27C-88845F1DF449Q42278528-10C3968F-04C8-48F1-AE90-E257CDE6C859Q42281604-2322E51E-D157-44A3-825D-3911C94EE379Q42284499-A7D9D5DC-3797-4FA2-81D8-3AA426C1D449Q42284787-6A5EA20F-7B31-443D-BD81-BA1227302820Q42286265-64E3D8AE-19E8-492D-8C0E-96231BF6D839Q42483481-66C4E101-4664-4A99-A314-46A2CF541753Q42483877-3DDA715A-F0C8-4F08-8A6A-B5A5BECC0F32Q42498580-BB0F9627-4B28-4573-9DD4-187428B96A8AQ42557968-586FF097-9130-470D-9C44-01CFB3E48E74Q42557970-438B030E-435E-4918-8ADD-95A7793DB623Q43546981-948E9267-6596-4828-B9EC-373C3B759434Q43570696-328BF601-2B2F-43B9-87B5-447BFFB90F29Q43732651-A53FF746-1520-4A71-8C58-7D80C73EA43DQ43795205-4F368548-F84A-4326-B21B-FDC6C9407473Q43828915-6BF127B3-1008-4764-8319-49D200B28101Q43888912-22225399-ECE1-4BC9-9946-57EAE0742A0A
P1433
Journal of neural transmission. Parkinson's disease and dementia section
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Springer Science+Business Media
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of neural transmission. Parkinson's disease and dementia section
@ast
Journal of neural transmission. Parkinson's disease and dementia section
@en
Journal of neural transmission. Parkinson's disease and dementia section
@es
Journal of neural transmission. Parkinson's disease and dementia section
@it
Journal of neural transmission. Parkinson's disease and dementia section
@nl
type
label
Journal of neural transmission. Parkinson's disease and dementia section
@ast
Journal of neural transmission. Parkinson's disease and dementia section
@en
Journal of neural transmission. Parkinson's disease and dementia section
@es
Journal of neural transmission. Parkinson's disease and dementia section
@it
Journal of neural transmission. Parkinson's disease and dementia section
@nl
altLabel
J Neural Transm Park Dis Dement Sect
@en
prefLabel
Journal of neural transmission. Parkinson's disease and dementia section
@ast
Journal of neural transmission. Parkinson's disease and dementia section
@en
Journal of neural transmission. Parkinson's disease and dementia section
@es
Journal of neural transmission. Parkinson's disease and dementia section
@it
Journal of neural transmission. Parkinson's disease and dementia section
@nl
P1055
P1156
P1476
Journal of neural transmission. Parkinson's disease and dementia section
@en